SAR of 4-Alkoxybenzoic Acid Inhibitors of the Trypanosome Alternative Oxidase

ACS Medicinal Chemistry Letters
2018.0

Abstract

The SAR of 4-hydroxybenzaldehyde inhibitors of the trypanosome alternative oxidase (TAO), a critical enzyme for the respiration of bloodstream forms of trypanosomes, was investigated. Replacing the aldehyde group with a methyl ester resulted in a 10-fold increase in TAO inhibition and activity against T. brucei. Remarkably, two analogues containing the 2-hydroxy-6-methyl scaffold (9e and 16e) displayed single digit nanomolar TAO inhibition, which constitute the most potent 4-alkoxybenzoic acid derivatives described to date. 9e was 50-times more potent against TAO and 10-times more active against T. brucei compared to its benzaldehyde analogue 1. The farnesyl derivative 16e was as potent a TAO inhibitor as ascofuranone with IC50 = 3.1 nM. Similar to ascofuranone derivatives, the 2-hydroxy and 6-methyl groups seemed essential for low nanomolar TAO inhibition of acid derivatives, suggesting analogous binding interactions with the TAO active site.

Knowledge Graph

Similar Paper

SAR of 4-Alkoxybenzoic Acid Inhibitors of the Trypanosome Alternative Oxidase
ACS Medicinal Chemistry Letters 2018.0
Imidazoline- and Benzamidine-Based Trypanosome Alternative Oxidase Inhibitors: Synthesis and Structure–Activity Relationship Studies
ACS Medicinal Chemistry Letters 2022.0
Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (ΔMTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against T. brucei and T. congolense
European Journal of Medicinal Chemistry 2018.0
Benzoic acid and pyridine derivatives as inhibitors of Trypanosoma cruzi trans-sialidase
Bioorganic & Medicinal Chemistry 2007.0
Tryptanthrin derivatives as Toxoplasma gondii inhibitors—structure–activity-relationship of the 6-position
Bioorganic & Medicinal Chemistry Letters 2013.0
1-Benzyl-3-aryl-2-thiohydantoin Derivatives as New Anti-Trypanosoma brucei Agents: SAR and in Vivo Efficacy
ACS Medicinal Chemistry Letters 2017.0
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent
ACS Medicinal Chemistry Letters 2019.0
African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase
European Journal of Medicinal Chemistry 2017.0
Inhibition of GABA shunt enzymes’ activity by 4-hydroxybenzaldehyde derivatives
Bioorganic & Medicinal Chemistry Letters 2006.0
Discovery of novel and potent benzhydryl-tropane trypanocides highly selective for Trypanosoma cruzi
Bioorganic & Medicinal Chemistry Letters 2010.0